Clinical Trial: Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: A Pilot Study of Mitoxantrone in Combination With Clofarabine (MITCL) in Children, Adolescents and Young Adults (CAYA) With Refractory/Relapsed Acute Leukemia or High Grade Non-Hodgkin Lymphoma

Brief Summary: The combination of mitoxantrone and clofarabine as reinduction therapy will be safe, well tolerated and effective in children, adolescents and young adults with poor risk refractory/relapsed acute leukemia and high grade non-Hodgkin lymphoma (NHL).